Cargando…
Towards Personalized Therapy of Aortic Stenosis
Calcific aortic stenosis (CAS) is the most common cause of acquired valvular heart disease in adults with no available pharmacological treatment to inhibit the disease progression to date. This review provides an up-to-date overview of current knowledge of molecular mechanisms underlying CAS pathobi...
Autores principales: | Mazur, Piotr, Kopytek, Magdalena, Ząbczyk, Michał, Undas, Anetta, Natorska, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708539/ https://www.ncbi.nlm.nih.gov/pubmed/34945764 http://dx.doi.org/10.3390/jpm11121292 |
Ejemplares similares
-
PAI-1 Overexpression in Valvular Interstitial Cells Contributes to Hypofibrinolysis in Aortic Stenosis
por: Kopytek, Magdalena, et al.
Publicado: (2023) -
Diabetes concomitant to aortic stenosis is associated with increased expression of NF-κB and more pronounced valve calcification
por: Kopytek, Magdalena, et al.
Publicado: (2021) -
Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes
por: Kopytek, Magdalena, et al.
Publicado: (2020) -
Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism
por: Ząbczyk, Michał, et al.
Publicado: (2021) -
Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes
por: Ząbczyk, Michał, et al.
Publicado: (2021)